Home Posts Tagged "X-Linked Retinitis Pigmentosa"

X-Linked Retinitis Pigmentosa

Biogen Pays $124 Million to Develop Gene-Based Therapies

Carrie Ann, July 3, 2015

Biogen Pays $124 Million to Develop Gene-Based Therapies

Featured Healthcare & Pharmaceutical Manufacturing & Retail NEWS

On Thursday, Biogen Inc. will enter into the area of eye-disease treatment by paying Applied Genetic Technologies Corp. (AGTC) about $124 million for licensing …

Aspiring Business Leaders Worldwide

X-Linked Retinitis Pigmentosa

Biogen Pays $124 Million to Develop Gene-Based Therapies

READ THE MAGAZINE

September 2020 Issue

Champions Of Change

Get Connected

YOU FIRST

About Industry Leaders Magazine

Get Connected

Recent Posts

Venezuela oil industry facing near collapse, inventories go up by 84%

Quibi shuts shop in 6 months, cites bad timing as the cause

GM’s Iconic off-roader GMC Hummer EV breaks the internet on debut

US DoJ brings lawsuit against Google for malpractices in business

Other Navigation

Leadership Story Of The Month

Jane Fraser to head Citigroup, first female to break the Wall Street Bank Glass ceiling

Aspiring Business Leaders Worldwide

Biogen Pays $124 Million to Develop Gene-Based Therapies

READ THE MAGAZINE

September 2020 Issue

Champions Of Change

Get Connected

YOU FIRST

Jane Fraser to head Citigroup, first female to break the Wall Street Bank Glass ceiling

Register today to get full access to:

PASSWORD RESET

Register today to get full access to:

Subscribe Plan Details

Register today to get full access to:

LOGIN